Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP510407.RAsfHJoZXC2BApY-QePna7EzUw9SlNb84OXjRTa5WWQCE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP510407.RAsfHJoZXC2BApY-QePna7EzUw9SlNb84OXjRTa5WWQCE130_assertion type Assertion NP510407.RAsfHJoZXC2BApY-QePna7EzUw9SlNb84OXjRTa5WWQCE130_head.
- NP510407.RAsfHJoZXC2BApY-QePna7EzUw9SlNb84OXjRTa5WWQCE130_assertion description "[In patients with stage III and IV disease, TATI tissue expression (P = 0.002) and elevated TATI concentration in serum (P = 0.048) were associated with adverse cancer-specific and progression-free survival in univariate analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP510407.RAsfHJoZXC2BApY-QePna7EzUw9SlNb84OXjRTa5WWQCE130_provenance.
- NP510407.RAsfHJoZXC2BApY-QePna7EzUw9SlNb84OXjRTa5WWQCE130_assertion evidence source_evidence_literature NP510407.RAsfHJoZXC2BApY-QePna7EzUw9SlNb84OXjRTa5WWQCE130_provenance.
- NP510407.RAsfHJoZXC2BApY-QePna7EzUw9SlNb84OXjRTa5WWQCE130_assertion SIO_000772 15269150 NP510407.RAsfHJoZXC2BApY-QePna7EzUw9SlNb84OXjRTa5WWQCE130_provenance.
- NP510407.RAsfHJoZXC2BApY-QePna7EzUw9SlNb84OXjRTa5WWQCE130_assertion wasDerivedFrom befree-20140225 NP510407.RAsfHJoZXC2BApY-QePna7EzUw9SlNb84OXjRTa5WWQCE130_provenance.
- NP510407.RAsfHJoZXC2BApY-QePna7EzUw9SlNb84OXjRTa5WWQCE130_assertion wasGeneratedBy ECO_0000203 NP510407.RAsfHJoZXC2BApY-QePna7EzUw9SlNb84OXjRTa5WWQCE130_provenance.